Extended phenotype description and new molecular findings in late onset glycogen storage disease type II: A northern Italy population study and review of the literature

Gauthier Remiche, Dario Ronchi, Francesca Magri, Costanza Lamperti, Andreina Bordoni, Maurizio Moggio, Nereo Bresolin, Giacomo P. Comi

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Glycogen storage disease type II (GSDII) is a lysosomal storage disorder caused by acid alpha-1,4-glucosidase deficiency and associated with recessive mutations in its coding gene GAA. Few studies have provided so far a detailed phenotypical characterization in late onset GSDII (LO-GSDII) patients. Genotype-phenotype correlation has been previously attempted with controversial results. We aim to provide an in-depth description of a cohort (n = 36) of LO-GSDII patients coming from the north of Italy and compare our population's findings to the literature. We performed a clinical record-based retrospective and prospective study of our patients. LO-GSDII in our cohort covers a large variability of phenotype including subtle clinical presentation and did not differ significantly from previous data. In all patients, molecular analysis disclosed GAA mutations, five of them being novel. To assess potential genotype-phenotype correlations we divided IVS1-32-13T>G heterozygous patients into two groups following the severity of the mutations on the second allele. Our patients harbouring "severe" mutations (n = 21) presented a strong tendency to have more severe phenotypes and more disability, more severe phenotypes and more disability, higher prevalence of assisted ventilation and a shorter time of evolution to show it. The determination of prognostic factors is mandatory in order to refine the accuracy of prognostic information, to develop follow-up strategy and, more importantly, to improve the decision algorithm for enzyme replacement therapy administration. The demonstration of genotype-phenotype correlations could help to reach this objective. Clinical assessment homogeneity is required to overcome limitations due to the lack of power of most studies.

Original languageEnglish
Pages (from-to)83-97
Number of pages15
JournalJournal of Neurology
Volume261
Issue number1
DOIs
Publication statusPublished - Jan 2014

Fingerprint

Glycogen Storage Disease Type II
Italy
Phenotype
Genetic Association Studies
Population
Mutation
Enzyme Replacement Therapy
Ventilation
Retrospective Studies
Alleles
Prospective Studies
Acids
Genes

Keywords

  • Correlation
  • Genotype
  • Glycogen storage disease type II (GSDII)
  • Phenotype
  • Prognosis
  • Review

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

@article{7b0deb0e9c9543a1ac102d35451352f4,
title = "Extended phenotype description and new molecular findings in late onset glycogen storage disease type II: A northern Italy population study and review of the literature",
abstract = "Glycogen storage disease type II (GSDII) is a lysosomal storage disorder caused by acid alpha-1,4-glucosidase deficiency and associated with recessive mutations in its coding gene GAA. Few studies have provided so far a detailed phenotypical characterization in late onset GSDII (LO-GSDII) patients. Genotype-phenotype correlation has been previously attempted with controversial results. We aim to provide an in-depth description of a cohort (n = 36) of LO-GSDII patients coming from the north of Italy and compare our population's findings to the literature. We performed a clinical record-based retrospective and prospective study of our patients. LO-GSDII in our cohort covers a large variability of phenotype including subtle clinical presentation and did not differ significantly from previous data. In all patients, molecular analysis disclosed GAA mutations, five of them being novel. To assess potential genotype-phenotype correlations we divided IVS1-32-13T>G heterozygous patients into two groups following the severity of the mutations on the second allele. Our patients harbouring {"}severe{"} mutations (n = 21) presented a strong tendency to have more severe phenotypes and more disability, more severe phenotypes and more disability, higher prevalence of assisted ventilation and a shorter time of evolution to show it. The determination of prognostic factors is mandatory in order to refine the accuracy of prognostic information, to develop follow-up strategy and, more importantly, to improve the decision algorithm for enzyme replacement therapy administration. The demonstration of genotype-phenotype correlations could help to reach this objective. Clinical assessment homogeneity is required to overcome limitations due to the lack of power of most studies.",
keywords = "Correlation, Genotype, Glycogen storage disease type II (GSDII), Phenotype, Prognosis, Review",
author = "Gauthier Remiche and Dario Ronchi and Francesca Magri and Costanza Lamperti and Andreina Bordoni and Maurizio Moggio and Nereo Bresolin and Comi, {Giacomo P.}",
year = "2014",
month = "1",
doi = "10.1007/s00415-013-7137-2",
language = "English",
volume = "261",
pages = "83--97",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "Dr. Dietrich Steinkopff Verlag GmbH and Co. KG",
number = "1",

}

TY - JOUR

T1 - Extended phenotype description and new molecular findings in late onset glycogen storage disease type II

T2 - A northern Italy population study and review of the literature

AU - Remiche, Gauthier

AU - Ronchi, Dario

AU - Magri, Francesca

AU - Lamperti, Costanza

AU - Bordoni, Andreina

AU - Moggio, Maurizio

AU - Bresolin, Nereo

AU - Comi, Giacomo P.

PY - 2014/1

Y1 - 2014/1

N2 - Glycogen storage disease type II (GSDII) is a lysosomal storage disorder caused by acid alpha-1,4-glucosidase deficiency and associated with recessive mutations in its coding gene GAA. Few studies have provided so far a detailed phenotypical characterization in late onset GSDII (LO-GSDII) patients. Genotype-phenotype correlation has been previously attempted with controversial results. We aim to provide an in-depth description of a cohort (n = 36) of LO-GSDII patients coming from the north of Italy and compare our population's findings to the literature. We performed a clinical record-based retrospective and prospective study of our patients. LO-GSDII in our cohort covers a large variability of phenotype including subtle clinical presentation and did not differ significantly from previous data. In all patients, molecular analysis disclosed GAA mutations, five of them being novel. To assess potential genotype-phenotype correlations we divided IVS1-32-13T>G heterozygous patients into two groups following the severity of the mutations on the second allele. Our patients harbouring "severe" mutations (n = 21) presented a strong tendency to have more severe phenotypes and more disability, more severe phenotypes and more disability, higher prevalence of assisted ventilation and a shorter time of evolution to show it. The determination of prognostic factors is mandatory in order to refine the accuracy of prognostic information, to develop follow-up strategy and, more importantly, to improve the decision algorithm for enzyme replacement therapy administration. The demonstration of genotype-phenotype correlations could help to reach this objective. Clinical assessment homogeneity is required to overcome limitations due to the lack of power of most studies.

AB - Glycogen storage disease type II (GSDII) is a lysosomal storage disorder caused by acid alpha-1,4-glucosidase deficiency and associated with recessive mutations in its coding gene GAA. Few studies have provided so far a detailed phenotypical characterization in late onset GSDII (LO-GSDII) patients. Genotype-phenotype correlation has been previously attempted with controversial results. We aim to provide an in-depth description of a cohort (n = 36) of LO-GSDII patients coming from the north of Italy and compare our population's findings to the literature. We performed a clinical record-based retrospective and prospective study of our patients. LO-GSDII in our cohort covers a large variability of phenotype including subtle clinical presentation and did not differ significantly from previous data. In all patients, molecular analysis disclosed GAA mutations, five of them being novel. To assess potential genotype-phenotype correlations we divided IVS1-32-13T>G heterozygous patients into two groups following the severity of the mutations on the second allele. Our patients harbouring "severe" mutations (n = 21) presented a strong tendency to have more severe phenotypes and more disability, more severe phenotypes and more disability, higher prevalence of assisted ventilation and a shorter time of evolution to show it. The determination of prognostic factors is mandatory in order to refine the accuracy of prognostic information, to develop follow-up strategy and, more importantly, to improve the decision algorithm for enzyme replacement therapy administration. The demonstration of genotype-phenotype correlations could help to reach this objective. Clinical assessment homogeneity is required to overcome limitations due to the lack of power of most studies.

KW - Correlation

KW - Genotype

KW - Glycogen storage disease type II (GSDII)

KW - Phenotype

KW - Prognosis

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=84895076399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895076399&partnerID=8YFLogxK

U2 - 10.1007/s00415-013-7137-2

DO - 10.1007/s00415-013-7137-2

M3 - Article

C2 - 24158270

AN - SCOPUS:84895076399

VL - 261

SP - 83

EP - 97

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

IS - 1

ER -